Influence of Cimicifuga Racemosa on the Proliferation of Estrogen Receptor-Positive Human Breast Cancer Cells Cornelia BodinetJohannes Freudenstein OriginalPaper Pages: 1 - 10
T1 Breast Cancer: Identification of Patients at Low Risk of Axillary Lymph Node Metastases Arnim A. BaderJoke TioAugustinus H. Tulusan OriginalPaper Pages: 11 - 17
Breast Cancers Found by Screening: Earlier Detection, Lower Malignant Potential or Both? Miranda F. ErnstJan A. RoukemaAdri C. Voogd OriginalPaper Pages: 19 - 25
Estrogen Receptor Breast Cancer Phenotypes in the Surveillance, Epidemiology, and End Results Database William F. AndersonNilanjan ChatterjeeOtis W. Brawley OriginalPaper Pages: 27 - 36
Prognostic Value of Residual Node Involvement in Operable Breast Cancer after Induction Chemotherapy Hervé CuréSophie AmatPhilippe Chollet OriginalPaper Pages: 37 - 45
Docetaxel Plus Vinorelbine as Salvage Chemotherapy in Advanced Breast Cancer: A Phase II Study Javier RodríguezEmiliano CalvoÓscar Fernández-Hidalgo OriginalPaper Pages: 47 - 56
Cyclooxygenase Inhibitors Block Cell Growth, Increase Ceramide and Inhibit Cell Cycle Namita KunduMiriam J. SmythAmy M. Fulton OriginalPaper Pages: 57 - 64
Progesterone Receptor Quantification as a Strong Prognostic Determinant in Postmenopausal Breast Cancer Women under Tamoxifen Therapy Pierre-Jean LamyPascal PujolJean Grenier OriginalPaper Pages: 65 - 71
Predictors of Sensitivity of Clinical Breast Examination (CBE) Nina OestreicherEmily WhiteStephen H. Taplin OriginalPaper Pages: 73 - 81
